CureVac (CVAC) Earnings Date, Estimates & Call Transcripts $3.47 -0.12 (-3.34%) Closing price 05/9/2025 04:00 PM EasternExtended Trading$3.43 -0.04 (-1.15%) As of 05:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CureVac Earnings Summary CureVac announced Q4 2024 earnings on April 10, 2025, reporting an EPS of -$0.15, which missed the consensus estimate of -$0.14 by $0.01. Quarterly revenue was reported to be $15.44 million, above analysts' expectations of $6.40 million. With a trailing EPS of $0.82 and a P/E Ratio of 6.31, CureVac's earnings are expected to decrease next year, from $0.72 to ($0.39) per share. Upcoming Earnings DateMay. 22Before Market OpensEstimatedConsensus EPS (Apr. 10) -$0.14 Actual EPS (Apr. 10) -$0.15 Missed By -$0.01 Actual Revenue (Apr. 10) $15.44MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Press Release (6-K) Annual Report (20-F)CVAC Upcoming EarningsCureVac's Q1 2025 earnings is scheduled for Thursday, May 22, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get CureVac Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CureVac and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCVAC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CVAC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. CureVac Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $0.72 EPSNext Year EPS Consensus Estimate ($0.39) EPS CureVac Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/22/2025(Estimated)-------4/10/2025Q4 2024-$0.14-$0.15 -$0.01-$0.15$6.40M$15.44M8/15/2024Q2 2024-$0.28-$0.34 -$0.06-$0.34$10.07M$15.55M5/23/2024Q4 2023-$0.22-$0.34 -$0.12-$0.34$14.51M$13.43M4/24/2024Q4 2023--$0.42 -$0.42-$0.42-$24.30M11/14/2023Q3 2023-$0.26-$0.24+$0.02-$0.24$15.01M$17.94M8/17/2023Q2 2023-$0.28-$0.33 -$0.05-$0.33$14.89M$8.25M5/30/2023Q1 2023-$0.29-$0.29--$0.29$16.45M$7.65M CureVac Earnings - Frequently Asked Questions When is CureVac's earnings date? CureVac has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 22nd, 2025 based off last year's report dates. Learn more on CVAC's earnings history. Did CureVac beat their earnings estimates last quarter? In the previous quarter, CureVac (NASDAQ:CVAC) missed the analysts' consensus estimate of ($0.14) by $0.01 with a reported earnings per share (EPS) of ($0.15). Learn more on analysts' earnings estimate vs. CVAC's actual earnings. How can I listen to CureVac's earnings conference call? The conference call for CureVac's latest earnings report can be listened to online. Listen to Conference Call How can I read CureVac's conference call transcript? The conference call transcript for CureVac's latest earnings report can be read online. Read Transcript How much revenue does CureVac generate each year? CureVac (NASDAQ:CVAC) has a recorded annual revenue of $535.18 million. How much profit does CureVac generate each year? CureVac (NASDAQ:CVAC) has a recorded net income of -$281.58 million. CVAC has generated $0.82 earnings per share over the last four quarters. What is CureVac's price-to-earnings ratio? CureVac (NASDAQ:CVAC) has a trailing price-to-earnings ratio of 6.31 and a forward price-to-earnings ratio of 4.82. What is CureVac's EPS forecast for next year? CureVac's earnings are expected to decrease from $0.72 per share to ($0.39) per share in the next year. More Earnings Resources from MarketBeat Related Companies Scholar Rock Earnings Results Merus Earnings Results Catalyst Pharmaceuticals Earnings Results Xenon Pharmaceuticals Earnings Results Protagonist Therapeutics Earnings Results MoonLake Immunotherapeutics Earnings Results Immunovant Earnings Results ACADIA Pharmaceuticals Earnings Results Metsera Earnings Results Alvotech Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:CVAC) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CureVac Please log in to your account or sign up in order to add this asset to your watchlist. Share CureVac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy cvac Stock Free cvac Stock Alerts